Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate Clinical research trials and Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate. Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate clinical trial. Human subjects often obtain the finest healthcare possible for their Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > "S" Clinical Trials Conditions > Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate

Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate



Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate

For Condition: Carcinoma, Squamous Cell
Status: Recruiting
Sponsor(s): Introgen Therapeutics ,
Synopsis: There is a need for more treatment options for patients with recurrent squamous cell cancer of the head and neck (SCCHN). These tumors usually have a variety of genetic defects that include disruption of the p53 pathway, a pathway that would ordinarily work to prevent the development of tumors. In this study the transfer of the p53 gene to tumor cells using a modified adenovirus (INGN 201) will be compared to methotrexate in patients who have failed surgery, radiotherapy and chemotherapy with platinum or taxanes.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - 18 years or older - Not eligible for surgery - Must have had radiation and chemotherapy treatments - No prior methotrexate treatments
Total Enrollment: 

Location and Contact Information:

University of Arkansas *Recruiting*
Little Rock,  Arkansas, 
United States
Recruiting  


Additional Information:
Study ID Numbers:  T301; 
Study Start Date: 
Record last reviewed: March 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00041613

Other Carcinoma, Squamous Cell Studies:
1. Study Of Zd1839 (Iressaâ„¢) Versus Methotrexate For Previously Treated Patients With Squamous Cell Carcinoma Of The Head And Neck

2. Effectiveness and Safety of INGN 201 in Combination with Chemotherapy Versus Chemotherapy Alone

3. Trial of Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer in Previously Treated Patients

4. A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer

5. Pilot Study of the Correlation Between the Findings of Atypical/Malignant Cells in Sputum and Fluorescence Bronchoscopy in Patients at Risk for Lung Cancer of the LIFE Imaging System and White Light Bronchoscopy

Related Studies:

Other Carcinoma, Squamous Cell Clinical Trials
Other Arkansas Clinical Trials
Other Little Rock Clinical Trials

Study to Compare the Overall Survival of Patients Receiving INGN 201 (study drug) with Patients Receiving Methotrexate
Modify your Search

  Other Carcinoma, Squamous Cell Clinical Trials
  Other Arkansas Clinical Trials
  Other Little Rock Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103